The RIQAS Epstein Barr Virus EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
- Liquid ready-to-use
- 100% human plasma
- Quarterly reporting (3 samples per quarterly distribution)
- Submit results and view reports online via RIQASNet
- Suitable for both quantitative and qualitative methods of analysis
Parameters
- Anti-EBNA IgG
- Anti-EBV VCA IgG
- Anti-EBV VCA IgM
Description | Size | Catalogue # |
---|---|---|
RIQAS Serology (Epstein Barr Virus) Programme | 3 x 1 ml | RQ9153 |